124 related articles for article (PubMed ID: 4990998)
1. Tetracycline levels in bronchial secretions.
Campbell MJ
J Clin Pathol; 1970 Jul; 23(5):427-34. PubMed ID: 4990998
[TBL] [Abstract][Full Text] [Related]
2. Doxycycline in serum and bronchial secretions.
Hartnett BJ; Marlin GE
Thorax; 1976 Apr; 31(2):144-8. PubMed ID: 821169
[TBL] [Abstract][Full Text] [Related]
3. Minocycline, doxycycline and tetracycline levels in serum and bronchial secretions of patients with chronic bronchitis.
Ruhen RW; Tandon MK
Pathology; 1975 Jul; 7(3):193-7. PubMed ID: 1196678
[TBL] [Abstract][Full Text] [Related]
4. Comparative effectiveness of tetracycline, minocycline and doxycycline in treatment of acute-on-chronic bronchitis. A study based on sputum levels.
Ruhen RW; Tandon MK
Med J Aust; 1976 Feb; 1(6):151-3. PubMed ID: 1083475
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of in vitro antibacterial potencies of oral antibiotics against sputum isolates].
Yamada H; Nakanishi H; Yamaguchi M; Nagasawa Z
Jpn J Antibiot; 1983 Aug; 36(8):2103-8. PubMed ID: 6361322
[TBL] [Abstract][Full Text] [Related]
6. Penetration of piperacillin into bronchial mucosa and sputum.
Marlin GE; Burgess KR; Burgoyne J; Funnell GR; Guinness MD
Thorax; 1981 Oct; 36(10):774-80. PubMed ID: 6460337
[TBL] [Abstract][Full Text] [Related]
7. [Tetracycline levels in the sputum in chronic obstructive bronchitis (author's transl)].
Zimmermann I; Ulmer WT; Ritzerfeld W
MMW Munch Med Wochenschr; 1977 Jun; 119(24):845-8. PubMed ID: 407472
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility of lower respiratory tract pathogens in Great Britain and Ireland 1999-2001 related to demographic and geographical factors: the BSAC Respiratory Resistance Surveillance Programme.
Reynolds R; Shackcloth J; Felmingham D; MacGowan A;
J Antimicrob Chemother; 2003 Dec; 52(6):931-43. PubMed ID: 14585865
[TBL] [Abstract][Full Text] [Related]
9. The isolation results and the antimicrobial agents susceptibility analysis of Haemophilus from the sputum of the elderly suffering from respiratory tract disease.
Liu JD; Lu HX; Hu L
Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 1999 Dec; 10(2):71-5. PubMed ID: 10681708
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
11. [Serum levels and sputum levels of cefmenoxime in respiratory tract infections].
Matsumoto Y; Ninomaru S; Koshobu T; Ishikawa J; Nakatani S; Sasaki T
Jpn J Antibiot; 1985 Jun; 38(6):1638-42. PubMed ID: 3862881
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic susceptibility in Streptococcus pneumoniae, Haemophilus influenzae and Streptococcus pyogenes in Pakistan: a review of results from the Survey of Antibiotic Resistance (SOAR) 2002-15.
Zafar A; Hasan R; Nizamuddin S; Mahmood N; Mukhtar S; Ali F; Morrissey I; Barker K; Torumkuney D
J Antimicrob Chemother; 2016 May; 71 Suppl 1(Suppl 1):i103-9. PubMed ID: 27048578
[TBL] [Abstract][Full Text] [Related]
13. Ampicillin levels in sputum, serum, and saliva.
Stewart SM; Fisher M; Young JE; Lutz W
Thorax; 1970 May; 25(3):304-11. PubMed ID: 4318047
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility of community-acquired respiratory tract pathogens in the UK during 2002/3 determined locally and centrally by BSAC methods.
Morrissey I; Robbins M; Viljoen L; Brown DF
J Antimicrob Chemother; 2005 Feb; 55(2):200-8. PubMed ID: 15649996
[TBL] [Abstract][Full Text] [Related]
15. [STUDY ON NEISSERIA IN BRONCHO-PULMONARY INFECTIONS].
BARTMANN K; BRANDT HJ; BLISSE A
Med Thorac; 1963; 20():341-57. PubMed ID: 14138588
[No Abstract] [Full Text] [Related]
16. A comparison of cefaclor and tetracycline in the treatment of bacterial bronchitis.
Hurst DJ
Clin Ther; 1984; 6(2):163-9. PubMed ID: 6231104
[TBL] [Abstract][Full Text] [Related]
17. Antibiotics in sinus secretions.
Burgi H; Kleber A; Regli J; Gent M
Lancet; 1968 Aug; 2(7564):406. PubMed ID: 4173809
[No Abstract] [Full Text] [Related]
18. Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden.
Kallings I; Bengtsson S; Christensen P; Holm SE; Lind L; Kalin M
Scand J Infect Dis Suppl; 1983; 39():100-5. PubMed ID: 6359377
[TBL] [Abstract][Full Text] [Related]
19. Design of a multiplex PCR for Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae and Chlamydophila pneumoniae to be used on sputum samples.
Strålin K; Bäckman A; Holmberg H; Fredlund H; Olcén P
APMIS; 2005 Feb; 113(2):99-111. PubMed ID: 15723684
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic resistance in Streptococcus pneumoniae and Haemophilus influenzae. Report of a study group on bacterial resistance.
Howard AJ; Hince CJ; Williams JD
Br Med J; 1978 Jun; 1(6128):1657-60. PubMed ID: 26450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
